RiverVest

Apr 23, 2009
Accumetrics, Inc. Announces United Kingdom Distribution Agreement with ELITech UK Limited
Mar 25, 2009
Calypso® Medical’s Customers Obtain Reimbursement for Intrafraction Tracking and Beacon® Transponders
Mar 18, 2009
U.S. Food and Drug Administration Clears Way for Multicenter Clinical Trial of IDev Technologies’ Supera Peripheral Stent
Mar 16, 2009
CyDex Pharmaceuticals Presents Phase 2 Clinical Trial Results for Captisol-Enabled® Budesonide/Azelastine Combination Solution Nasal Spray at American Academy of Allergy Asthma and Immunology (AAAAI) Meeting

RiverVest Venture Partners® is a venture capital firm focused on identifying and shaping early-stage life science companies to create significant shareholder value. With hands-on, high-level expertise and financial resources, RiverVest supports entrepreneurs by helping them achieve near-term objectives that position their companies for exit.

Case Study:

VC Partner as Sounding Board

Salient Surgical Technologies, Inc., founded as TissueLink Medical, Inc. in 1999, has successfully achieved market acceptance and strong revenue growth. But it took steady leadership and some skillful maneuvering to manage the inevitable bumps along the way. Read more >

“To have a trusted advisor — someone I can count on no matter how difficult the conversation? That’s worth its weight in gold!” — Joe Army, CEO - Salient Surgical Technologies, Inc.